INTL MEDICATION FDA Approval ANDA 062426

ANDA 062426

INTL MEDICATION

FDA Drug Application

Application #062426

Application Sponsors

ANDA 062426INTL MEDICATION

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001INJECTABLE;INJECTIONEQ 500MG BASE/VIAL0CEPHALOTHINCEPHALOTHIN SODIUM
002INJECTABLE;INJECTIONEQ 1GM BASE/VIAL0CEPHALOTHINCEPHALOTHIN SODIUM
003INJECTABLE;INJECTIONEQ 2GM BASE/VIAL0CEPHALOTHINCEPHALOTHIN SODIUM
004INJECTABLE;INJECTIONEQ 4GM BASE/VIAL0CEPHALOTHINCEPHALOTHIN SODIUM

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62426
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.